Underpowered or negative? A crucial distinction

Overview of attention for article published in Diabetologia, March 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (70th percentile)

Mentioned by

twitter: 7 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 15 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 6,925 followers.

RT @VibeNylander: This is a super important discussion, happy to see authors publically addressing misrepresentation of their clinical stud…

07 Apr 2019

Reply Repost Favourite

RT @VibeNylander: This is a super important discussion, happy to see authors publically addressing misrepresentation of their clinical stud…

06 Apr 2019

Reply Repost Favourite

This is a super important discussion, happy to see authors publically addressing misrepresentation of their clinical studies!

06 Apr 2019

Reply Repost Favourite

https://t.co/jTI8f3MALt Dollerup, Treebak and Jessen defends their clinical trial after it was dismissed as being underpowered in a recent review in #diabetologia

05 Apr 2019

Reply Repost Favourite

RT @TBergishagen: Underpowered or negative?Skarpt indlæg fra @treebak #Nielsjessen #Oledollerup i @DiabetologiaJnl om at negative fund, he…

28 Mar 2019

Reply Repost Favourite

Underpowered or negative?Skarpt indlæg fra @treebak #Nielsjessen #Oledollerup i @DiabetologiaJnl om at negative fund, her kosttilskud-ikke behøver at være et resultat af for få inkluderede patienter - men det faktum at den ingen signifikant effekt var.htt